These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 18722078)

  • 1. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
    Lips DJ; Barker N; Clevers H; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Abnormalities of chromosome 8, APC and beta-catenin genes in aggressive fibromatosis].
    Yang JL; Wang J; Zhou XY; Zhu XZ
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):116-20. PubMed ID: 18646694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
    Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
    Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.
    Kohler EM; Chandra SH; Behrens J; Schneikert J
    Hum Mol Genet; 2009 Jan; 18(2):213-26. PubMed ID: 18854359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic deletion of receptor for hyaluronan-mediated motility (Rhamm) attenuates the formation of aggressive fibromatosis (desmoid tumor).
    Tolg C; Poon R; Fodde R; Turley EA; Alman BA
    Oncogene; 2003 Oct; 22(44):6873-82. PubMed ID: 14534534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
    Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
    Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Agressive fibromatosis: genetic and biological correlations].
    Hlavatá Z; Porsok S
    Klin Onkol; 2012; 25(2):85-90. PubMed ID: 22533881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequent mutations in the beta-catenin gene in desmoid tumors from patients without familial adenomatous polyposis.
    Miyoshi Y; Iwao K; Nawa G; Yoshikawa H; Ochi T; Nakamura Y
    Oncol Res; 1998; 10(11-12):591-4. PubMed ID: 10367940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
    Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
    Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. APC mutations in FAP-associated desmoid tumours are non-random but not 'just right'.
    Latchford A; Volikos E; Johnson V; Rogers P; Suraweera N; Tomlinson I; Phillips R; Silver A
    Hum Mol Genet; 2007 Jan; 16(1):78-82. PubMed ID: 17135276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor).
    Tejpar S; Nollet F; Li C; Wunder JS; Michils G; dal Cin P; Van Cutsem E; Bapat B; van Roy F; Cassiman JJ; Alman BA
    Oncogene; 1999 Nov; 18(47):6615-20. PubMed ID: 10597266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
    Signoroni S; Frattini M; Negri T; Pastore E; Tamborini E; Casieri P; Orsenigo M; Da Riva L; Radice P; Sala P; Gronchi A; Bertario L; Pierotti MA; Pilotti S
    Clin Cancer Res; 2007 Sep; 13(17):5034-40. PubMed ID: 17785554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
    Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
    Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours.
    Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A
    Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
    Coffin CM; Hornick JL; Zhou H; Fletcher CD
    Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenomatous polyposis coli alteration in digestive endocrine tumours: correlation with nuclear translocation of beta-catenin and chromosomal instability.
    Pizzi S; Azzoni C; Tamburini E; Bottarelli L; Campanini N; D'Adda T; Fellegara G; Luong TV; Pasquali C; Rossi G; Delle Fave G; Camisa R; Bordi C; Rindi G
    Endocr Relat Cancer; 2008 Dec; 15(4):1013-24. PubMed ID: 18632876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggressive fibromatosis (desmoid tumors): definition, occurrence, pathology, diagnostic problems, clinical behavior, genetic background.
    Ferenc T; Sygut J; Kopczyński J; Mayer M; Latos-Bieleńska A; Dziki A; Kulig A
    Pol J Pathol; 2006; 57(1):5-15. PubMed ID: 16739877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.